Sachs discusses drug pricing reforms

Rachel Sachs, a health policy and drug law expert at the School of Law, discusses federal legislation that seeks to control drug prices on “Tradeoffs,” a national health policy podcast — and what the measure could mean for patients, insurers and pharmaceutical companies.

Why is Spire misleading its customers?

The one thing that is easy to see is that we did not need a new pipeline. So Spire is misleading the public, writes anthropology’s Bret Gustafson.

‘Literary invention in the age of disorder’

In a new book, Wolfram Schmidgen, professor of English in Arts & Sciences, explains how the excitement and anxiety about a disordered world affected literary invention in 18th-century England.
View More Stories